Kerstin Vokinger

Prof. Kerstin Vokinger is an Associate Professor at the Department of Health Sciences and Technology, ETH Zurich. Her research focuses on pharmaceutical economics, healthcare policy, AI in medicine, and regulatory science. She investigates drug pricing strategies, managed entry agreements, and the therapeutic value of medicines. Her work often compares policies between the US, Europe, and Switzerland, addressing issues like cancer drug pricing, orphan drug designation, and AI-based medical devices' regulation.

Key research areas include:

• Clinical trial outcomes and drug approval processes
• Health technology assessment and cost-effectiveness analysis
• Legal frameworks governing healthcare innovation
• Data privacy in medical research and AI applications

Her recent articles analyze trends such as the 'cancer premium' in drug pricing, the impact of expedited approvals on therapeutic value, and global disparities in cancer drug access. She also explores regulatory challenges in AI-driven medical devices and the ethical implications of anonymized healthcare data.

Prof. Vokinger collaborates with institutions worldwide to shape evidence-based health policies and improve drug affordability. Her work bridges legal, economic, and scientific dimensions of healthcare systems.